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A novel pH-sensitive (±)-α-tocopherol-5-fluorouracil adduct with antioxidant and anticancer properties
to each well and the plates were incubated for another 4 h at 37 °C under 5% CO 2 . After the medium was removed, the plates were added with DMSO (150 μL) and shaken to dissolve the formazan products. Multiscan MK3 microplate reader was used to measure the OD490 of each well. The cell survival rate in the control wells without the drugs solutions were considered as 100% cell survival.
Fluorescence spectra, UV-visible absorption spectra and circular dichroism (CD) spectra. β-sheet and unordered was calculated using SELCON3 and the differential was compared.
Electrochemical impedance spectroscopy (EIS) experiment.
Impedance Measurements Impedance measurements were done in a classical three electrode electrochemical testing system: as a working electrode (WE) a gold disk electrode (diameter = 2 mm) modified with SA was used, as a reference electrode (RE) was dropped to the surface of the electrode. After 15 h, the electrode was washed by ultrapure water several times and dried in nitrogen airflow, then ready for use.
-3 mol·L -1 K 3 Fe(CN) 6 /K 4 Fe(CN) 6 and 10 × 10 -3 mol·L -1 KCl at pH 7.4. Active surfaces of WE, RE and CE were contacting with electrolyte and were confined with an O-ring. 10 mL electrolyte was added to an electrochemical cell of 15 mL with a magnetic stirring device. Then, various volumes of VE-5-FU solutions were added continuously to the system and stirred for 30 seconds then rest 15 seconds before testing. The EIS were measured with the frequency from 0.1 to 100 000 Hz, and analyzed by a Z-view software to get the R ct . All measurements were repeated three times with different electrodes at room temperature.
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Atom force microscopy (AFM). The AFM measurements were performed with a scanning probe microscope "DI Nanoscope Ⅳ" from Veeco, U.S.A. The measurements were carried out in the tapping mode with a silicon nitride cantilever in a triangular shape.
Site marker competitive experiments. Binding studies between VE-5-FU and SA in the presence of two site markers (Warfarin and Ibuprofen) were measured using the fluorescence titration methods. The concentrations of SA and Warfarin/Ibuprofen were all stabilized at 10 μM. VE-5-FU was then gradually added to the SA-Warfarin or SA-Ibuprofen mixtures. An excitation wavelength of 280 nm was selected and the fluorescence spectra were recorded in the range of 300-500 nm at room temperature.
Molecule docking investigation.
The 3D structure of BSA was modeled using Modeller_9v7. The amino acid mmol) was dissolved in water (30 mL) containing potassium hydroxide (KOH, 2.8 g, 50 mmol), α-chloroacetic acid (2.37 g, 25 mmol) was then added to the solution, and the mixture was stirred at 100℃ for 2 h, keeping pH of the solution 10 by 10% KOH solution. After the reaction, solution was cooled to room temperature (r.t.), hydrogen chloride (HCl) was added to adjust pH to 2, and the resulting precipitate was filtrated.
Obtained powder was re-dissolved in a saturated potassium hydrogen carbonate solution, the solution was acidified to pH 2 by HCl, and the resulting precipitate was filtrated (4g colorless needles, 85% yield).
H NMR (300MHz, CDCl 3
The synthesis of (±)-α-tocopherol The influence of VE-5-FU on secondary structure of SA As shown in Fig. S4 , VE-5-FU-SA displayed the characteristic double negative peaks at 208 and 222 nm, similar to those of SA under native conditions, indicating that the α-helix rich structure was preserved after adding VE-5-FU. The contents of β-sheet and unordered calculated by SELCON3 also suggested that the binding of VE-5-FU to SA had no significant impact on the secondary structure of SA, and therefore, VE-5-FU could be successfully carried by SA without detriment to its function.
The confirmation of binding mechanism and binding number of spectroscopy to obtain spectra, the UV-vis absorption spectra of SA and the difference absorption spectra between VE-5-FU-SA and VE-5-FU at the same concentration could not be superposed within experimental error (Fig. S5 ). This result confirmed that the probable binding mechanism of VE-5-FU to SA was a complex formation process, rather than a collision process.
In order to assess the binding number of the VE-5-FU and SA system, we used the double-logarithmic equation (eq 2) to analyze the fluorescence data. carried out by using warfarin and ibuprofen which specifically bound to sites I and II on SA.
In the site marker competitive experiments, VE-5-FU was gradually added to the solution of SA and site markers held in equimolar concentrations (10 μM). As shown in wavelength of SA had a slight shift, and the fluorescence intensity was significantly lower than that of without warfarin. Then, with the addition of VE-5-FU, the fluorescence intensity of the SA-warfarin (1:1) decreased gradually, indicating that the bound VE-5-FU to SA was obviously affected by adding warfarin. By contrast, with the presence of ibuprofen, the fluorescence property of the VE-5-FU-SA system was almost the same as in the absence of ibuprofen (Fig. S6 c) , which indicated that site II marker ibuprofen did not prevent the binding of VE-5-FU in its usual binding location.
These results indicated that the binding site of VE-5-FU was mainly located within the site I of SA. 
Detailed illustration of H-bond between VE-5-FU and Arg218
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